Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Live Chat Live Help Software for Website

In Vitro Diagnostics Deals: Therapeutic Area Trends

Decision Resources, Inc, Dec 2006, Pages: 27


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: an estimated 60-70% of medical decisions involve a diagnostic test. This report focuses on IVD industry deals of the last few years and what they reveal about the current strategies of some of the industry’s larger and smaller companies.

Get the Answers You Need to Shape Your Strategy

Currently, IVD company revenues pale in comparison to those of the larger biopharmaceutical companies, but there are signs of steady growth in this highly segmented market.

What is the value of today’s global IVD market?
How fast is it growing?
Which segments are currently most profitable?
Which are showing strong growth?
Which IVD suppliers accounted for nearly 80% of worldwide sales in 2005?

Several large IVD M&As have occurred in recent years, but licensing deals have been the most common type.

How do licensing deals benefit IVD suppliers?
What do big pharmaceutical and diagnostics companies gain?
Which companies have been most active in M&A and licensing deals?
What does this activity indicate about the future of the IVD industry?

The overall oncology therapeutic area has accounted for the majority of IVD deals to date.

Which oncology segments are most active?
What other therapeutic areas are generating notable deals?
What types of diagnostic assays and tests are most in demand?
Which are being offered as “companion diagnostics” to therapeutic agents?
What new, DNA-based tests are in development?

Scope

The IVD marketplace: Current size, growth, segmentation, disease areas, major and
smaller IVD suppliers, 2005 sales.

IVD mergers and acquisitions: 2005-2006, companies, segments, values, significance.

IVD deals by disease areas: Oncology, cardiovascular, infectious diseases, other therapeutic areas.

IVD deal strategies: Different strategies drive deals in different tiers of the IVD industry.

Future IVD deals: Potential mergers and acquisitions as diagnostics change and the
IVD market continues to grow.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds